XML 87 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Goodwill and Other Intangible Assets (Tables)
 3 Months Ended
Mar. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The following table provides the components of and changes in the carrying amount of Goodwill:
(MILLIONS OF DOLLARS)
 
Primary
Care

 
Specialty
Care and
Oncology

 
Established
Products and
Emerging
Markets

 
Other Operating Segments(a)

 
Total

Balance, December 31, 2012
 
$
6,152

 
$
16,885

 
$
18,603

 
$
3,032

 
$
44,672

Derecognition(b)
 
—

 
—

 
(272
)
 
—

 
(272
)
Other(c)
 
(97
)
 
(266
)
 
(288
)
 
3

 
(648
)
Balance, March 31, 2013
 
$
6,055

 
$
16,619

 
$
18,043

 
$
3,035

 
$
43,752

(a) 
Reflects amounts associated with Animal Health (Zoetis) and Consumer Healthcare.
(b) 
Reflects the goodwill derecognized as part of the transfer of certain product rights, which constituted a business, to our equity-method investment in China. For additional information, see Note 2D. Acquisitions, Divestitures, Collaborative Arrangement and Equity-Method Investment: Equity-Method Investment.
(c) 
Primarily reflects the impact of foreign exchange.
Schedule of Finite Lived And Indefinite Lived Intangible Assets
The following table provides the components of Identifiable intangible assets:
 
 
March 31, 2013
 
December 31, 2012
(MILLIONS OF DOLLARS)
 
Gross
Carrying
Amount

 
Accumulated
Amortization

 
Identifiable
Intangible
Assets, less
Accumulated
Amortization

 
Gross
Carrying
Amount

 
Accumulated
Amortization

 
Identifiable
Intangible
Assets, less
Accumulated
Amortization

Finite-lived intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
Developed technology rights
 
$
73,310

 
$
(38,857
)
 
$
34,453

 
$
73,112

 
$
(37,069
)
 
$
36,043

Brands
 
1,880

 
(809
)
 
1,071

 
1,873

 
(781
)
 
1,092

License agreements and other
 
1,078

 
(817
)
 
261

 
1,085

 
(793
)
 
292

 
 
76,268

 
(40,483
)
 
35,785

 
76,070

 
(38,643
)
 
37,427

Indefinite-lived intangible assets
 
 

 
 

 
 

 
 

 
 

 
 

Brands
 
7,571

 
—

 
7,571

 
7,828

 
—

 
7,828

In-process research and development
 
681

 
—

 
681

 
688

 
—

 
688

Trademarks/tradenames
 
72

 
—

 
72

 
70

 
—

 
70

 
 
8,324

 
—

 
8,324

 
8,586

 
—

 
8,586

Identifiable intangible assets(a)
 
$
84,592

 
$
(40,483
)
 
$
44,109

 
$
84,656

 
$
(38,643
)
 
$
46,013

(a) 
The decrease is primarily related to amortization, an asset impairment charge and the transfer of certain product rights to our equity-method investment in China. For additional information about the asset impairment charge, see Note 4. Other Deductions—Net. For additional information about the transfer of certain product rights, see Note 2D. Acquisitions, Divestitures, Collaborative Arrangement and Equity-Method Investment: Equity-Method Investment.